remodel trial semaglutide Hemoglobin A1c Reduction With the GLP-1 Receptor Agonist Is Independent of Baseline eGFR: post hoc Analysis of the SUSTAIN and PIONEER Programs Semaglutides Are Poised to Remake

Durelli L, Ferrero B, Oggero A, Verdun E, Ghezzi A, Montanari E, et al

It's often seen as a way to reset the body, promote weight loss, and enhance mental clarity

The approved NHS pathways are: Wegovy (semaglutide) licensed for weight management via NICE TA875 (BMI 35+ with one condition, via tier 3 services) and NICE cardiovascular guidance April 2026 (BMI 27+ with established CVD, via GP) Mounjaro (tirzepatide) licensed for weight management via NICE TA1026 (BMI 35+ with four conditions from June 2026, via tier 3 or QOF GP pathway) Ozempic (semaglutide) NOT approved for NHS weight management

When doing an intramuscular injection they will use one needle to draw the fluid up into the syringe and then change that and use a second to actually inject using a clean needle

The FDA began allowing the distribution of compounded semaglutide and tirzepatide when both drugs were initially placed on the agencys drug shortage list in 2022